These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15928305)

  • 21. [Follow-up of a cohort of 2604 colorectal adenomas treated in 1991 and 1992. Search for parameters related to adenomatous recurrence].
    Le Bodic L; Cerbelaud C; Bouchand S; Auffret N; Clément A; Le Bodic MF
    Gastroenterol Clin Biol; 2003 May; 27(5):466-70. PubMed ID: 12843910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selenium and colorectal adenoma: results of a pooled analysis.
    Jacobs ET; Jiang R; Alberts DS; Greenberg ER; Gunter EW; Karagas MR; Lanza E; Ratnasinghe L; Reid ME; Schatzkin A; Smith-Warner SA; Wallace K; Martínez ME
    J Natl Cancer Inst; 2004 Nov; 96(22):1669-75. PubMed ID: 15547179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
    Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A
    Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
    Colombo C; Battezzati PM; Podda M; Bettinardi N; Giunta A
    Hepatology; 1996 Jun; 23(6):1484-90. PubMed ID: 8675168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study.
    van Heijningen EM; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Lesterhuis W; Ter Borg F; Vecht J; De Jonge V; Spoelstra P; Engels L; Bolwerk CJ; Timmer R; Kleibeuker JH; Koornstra JJ; van Ballegooijen M; Steyerberg EW
    Gastroenterology; 2013 Jun; 144(7):1410-8. PubMed ID: 23499951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy.
    Avidan B; Sonnenberg A; Schnell TG; Leya J; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Jun; 97(6):1524-9. PubMed ID: 12094877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ursodeoxycholic acid and chemoprevention of colorectal cancer.
    Serfaty L; Bissonnette M; Poupon R
    Gastroenterol Clin Biol; 2010 Oct; 34(10):516-22. PubMed ID: 20609543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of regular follow-up after removal of colorectal adenomas].
    Schwenk W; Osswald J; Huppa C; Stock W
    Med Klin (Munich); 1993 Aug; 88(8):471-7. PubMed ID: 8413048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.
    Thompson PA; Wertheim BC; Roe DJ; Ashbeck EL; Jacobs ET; Lance P; Martínez ME; Alberts DS
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1023-30. PubMed ID: 19952360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and recurrence rates of colorectal adenomas in first-degree asymptomatic relatives of patients with colon cancer.
    Fossi S; Bazzoli F; Ricciardiello L; Nicolini G; Zagari RM; Pozzato P; Palli D; Roda E
    Am J Gastroenterol; 2001 May; 96(5):1601-4. PubMed ID: 11374706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
    Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
    JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large size, villous content and distal location are associated with severe dysplasia in colorectal adenomas.
    Giuliani A; Caporale A; Corona M; Ricciardulli T; Di Bari M; Demoro M; Scarpini M; Angelico F
    Anticancer Res; 2006; 26(5B):3717-22. PubMed ID: 17094390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic model for patients treated for colorectal adenomas with regard to development of recurrent adenomas and carcinoma.
    Jensen P; Krogsgaard MR; Christiansen J
    Eur J Surg; 1996 Mar; 162(3):229-34; discussion 235. PubMed ID: 8695739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biopsy of colorectal polyps is not adequate for grading of neoplasia.
    Gondal G; Grotmol T; Hofstad B; Bretthauer M; Eide TJ; Hoff G
    Endoscopy; 2005 Dec; 37(12):1193-7. PubMed ID: 16329016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study.
    Wallace K; Byers T; Morris JS; Cole BF; Greenberg ER; Baron JA; Gudino A; Spate V; Karagas MR
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):464-7. PubMed ID: 12750244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of ursodesoxycholic acid on duodenal adenomas in familial adenomatous polyposis: a prospective randomized placebo-control trial.
    Parc Y; Desaint B; Fléjou JF; Lefèvre JH; Serfaty L; Vienne A; Kotti S; Simon T; Tiret E
    Colorectal Dis; 2012 Jul; 14(7):854-60. PubMed ID: 21899713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of proximal neoplasia in patients without distal adenomatous pathology.
    Anderson JC; Alpern Z; Messina CR; Lane B; Hubbard P; Grimson R; Ells PF; Brand DL
    Am J Gastroenterol; 2004 Mar; 99(3):472-7. PubMed ID: 15056088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum ferritin concentration and recurrence of colorectal adenoma.
    Tseng M; Greenberg ER; Sandler RS; Baron JA; Haile RW; Blumberg BS; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):625-30. PubMed ID: 10868699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fat, fiber, meat and the risk of colorectal adenomas.
    Robertson DJ; Sandler RS; Haile R; Tosteson TD; Greenberg ER; Grau M; Baron JA
    Am J Gastroenterol; 2005 Dec; 100(12):2789-95. PubMed ID: 16393237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.